Loading...
XNAS
NEOG
Market cap2.74bUSD
Sep 16, Last price  
12.55USD
Name

Neogen Corp

Chart & performance

D1W1MN
XNAS:NEOG chart
P/E
P/S
3.14
EPS
Div yield, %
Shrs. gr., 5y
15.22%
Rev. gr., 5y
13.19%
Revenues
870m
-2.71%
86,138,000102,418,000118,721,000140,509,000172,683,000184,046,000207,528,000247,405,000283,074,000321,275,000358,277,000397,930,000414,186,000418,170,000468,459,000527,159,000822,447,000924,222,000894,661,000870,400,000
Net income
-8m
L-99.28%
9,125,00012,098,00013,874,00017,521,00022,839,00022,513,00027,190,00028,158,00033,526,00036,564,00043,793,00063,145,00060,176,00059,475,00060,882,00048,307,000-22,870,000-9,421,000-1,092,044,000-7,900,000
CFO
83m
+42.85%
10,158,0007,873,00010,985,00027,988,00028,843,00022,277,00026,561,00021,668,00043,792,00035,331,00060,274,00069,131,00063,842,00085,878,00081,089,00068,038,00041,028,00035,264,00058,244,00083,200,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

Key people

John Edward Adent
President, Chief Executive Officer · since 2017
Terri A. Morrical
Vice President - Animal Safety · since 2006
Stewart Bauck
Vice President - Agrigenomics · since 2016
Joseph A. Corbett
Vice President - Animal Safety Sales · since 2019
Robert S. Donofrio
Vice President - Food Safety Research and Development · since 2018
Shane M. Fitzwater
Vice President, Animal Safety Operations · since 2018
Jerome L. Hagedorn
Vice President - food safety operations · since 2018
Melissa Herbert
Vice President - Support Services · since 2015
Jason Warren Lilly
Vice President - International Business · since 2019
Steven J. Quinlan
Chief Financial Officer, Vice President · since 2011
Jack C. Parnell
Lead Independent Director · since 2006
Chairman of the Board · since 2020
William T. Boehm
Independent Director · since 2011
Ronald D. Green
Independent Director · since 2014
G. Bruce Papesh
Independent Director · since 1999
James P. Tobin
Independent Director · since 2016
Darci L. Vetter
Independent Director · since 2017
IPO date
Aug 23, 1989
Employees
2,640
Domiciled in
US
Incorporated in
US
Headquarters & legal address
C/O James L Herbert Jr.
620 Lesher Place
Lansing, MI 48912
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑052025‑052024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT